(GLOBE NEWSWIRE) -- Ltd. (ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced financial results for the first quarter ended March 31, 2016. "During the first quarter, we announced positive final results of our ... Yahoo! Finance, 3 hours ago
Biostar Pharmaceuticals Announces Its Quarterly Results for Three Months Ended March 31, 2016 - FirstWord Pharma, 1 day ago
Acceleron Pharma Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)] (May. 5, 2016) - Pharmacy Choice, 2 days ago
PDL BioPharma Commits to Equity Investment in Noden Pharma for the Acquisition of Tekturna® (aliskiren) and Tekturna HCT® (aliskiren and hydrochlorothiazide)
--Transaction Represents First Specialty Pharmaceutical Transaction by PDL-- --Upon Close, Transaction Expected to be Immediately Accretive-- 16:02 ET from PDL BioPharma, Inc. INCLINE VILLAGE, Nev., May 24, 2016 /PRNewswire/ -- PDL BioPharma, ...PR Newswire, 19 hours ago PDL Bio acquires anti-hypertension drugs from Novartis for up to $145M Seeking Alpha, 18 hours ago BRIEF-PDL Biopharma says agreed to equity investment in Noden Pharma Reuters UK, 19 hours ago Acadian Asset Management LLC Lowers Position in PDL BioPharma Inc (PDLI) Mideast Time, 19 hours ago
Management Files First Quarter 2016 FinancialsSan Diego, CA -- (ReleaseWire) -- 05/20/2016 -- Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCQB Venture Market: INNV), an emerging commercial stage pharmaceutical company that delivers safe, ...4 Traders, 5 days ago INNOVUS PHARMACEUTICALS : Pharma Signs Exclusive License and Distribution Agreement With BroadMed for EjectDelay in Lebanon 4 Traders, 5 hours ago Upcoming PDUFA and ANDA Approval Dates Could Catalyze Innovus Pharma (INNV) and Lipocine (LPCN) BioMedReports, 2 days ago Innovus Pharma Signs Exclusive License and Distribution Agreement With BroadMed for EjectDelay in Lebanon Canadian Business Journal, 4 hours ago
Bengaluru, May 25 (UNI) Pharma major Glenmark Pharmaceuticals Ltd today launched 'Digihaler', country's first Digital Dose Inhaler that provides accurate digital dose counter to enable Asthma and chronic obstructive pulmonary disease (COPD) ...United News of India, 2 hours ago Glenmark launches measurable inhaler for asthma, COPD patients Yahoo! India, 3 hours ago
Thunderbolt Pharma, Inc., a Vitesse Biologics Company, Acquires Rights to BAFF/APRIL Dual Antagonist Program from Astellas Pharma Inc.
First company established under Vitesse Biologics, an innovative collaboration formed by Baxalta, Mayo Clinic and Velocity Pharmaceutical Development Thunderbolt Pharma, Inc., will use technology to develop potential treatments for systemic lupus ...CNBC, 15 hours ago Astellas Sells BAFF/APRIL Dual Antagonist Program Genetic Engineering News, 1 hour ago Baxalta, Mayo and Velocity license Astellas lupus platform for upstart FierceBiotech, 1 hour ago BAXALTA : Thunderbolt Pharma, Inc., a Vitesse Biologics Company, Acquires Rights to BAFF/APRIL Dual Antagonist Program from Astellas Pharma Inc. 4 Traders, 15 hours ago
Aurobindo was one of the first ANDA applicants to submit a substantially complete ANDA with a paragraph IV certification, therefore, Aurobindo is eligible for 180 days of generic drug shared exclusivity. The launch of this product will be based on the outcome ...India Infoline, 3 weeks ago Aurobindo Pharma receives nod from USFDA for manufacturing cholesterol tablets First Post.com, 2 weeks ago Ajanta Pharma gets FDA nod for migraine pain relief drug FirstWord Pharma, 21 hours ago Sun Pharma receives USFDA approval for BromSite India Infoline, 1 month ago
There are two pharmaceutical industries in India -The first sells its produce in large volumes in quality-conscious United States, the gold standard, while the second sells chalta hai medicine within the country without fear, notes Bhupesh Bhandari. Image: Dinesh Thakur fights against sub-standard medicine. Photograph: Anindito Mukherjee/Reuters Dinesh Thakur, the Ranbaxy whistleblower, seems to be waging a lone battle against sub-standard medicine. After the Supreme ...Rediff.com, 2 weeks ago
The project will first be launched in malaria-ridden district of Mandla in Madhya Pradesh, says Altaf Lal, Senior Advisor, Global Health Innovation at Sun Pharma.Money Control, 4 weeks ago
Shri J P Nadda announces PPP between ICMR and Sun Pharma in research & innovation in preventive health
Shri J P Nadda, Union Minister of Health & Family Welfare announced India’s first public-private-partnership (PPP) agreement for research and innovation in preventive health between ICMR and Sun Pharma, here today. Presiding over the signing of this ...PIB, 4 weeks ago Nadda announces PPP between ICMR, Sun Pharma in research, innovation in preventive health Sify, 4 weeks ago
Major domestic firms such as Sun Pharma, Lupin, Glenmark, Aurobindo, Alembic and Hetero Labs figure in the list of first-time generic drug approvals released by the FDA's Office of Generic Drugs.Money Control, 1 month ago Indian cos get USFDA nod for 14 1st-time generic drugs in 2015 Business Standard, 1 month ago Indian companies get USFDA nod for 14 1st-time generic drugs in 2015 DNA, 1 month ago
on your WebpageAdd Widget >Get your members hooked!